Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Real-world pharmacovigilance studies (which track adverse events reported after medications are on the market) show mixed results
Obesity is more complicated than a simple imbalance of the hormone mimicked by these drugs, but doctors do now generally consider it a chronic disease
We accept all major insurance plans and streamline the prior authorization process, taking care of every detail to ensure your treatment journey is as smooth as possible
they are part of a structured, physician-directed approach that elevates how we think about body transformation
In the pivotal trials, tirzepatide 15 mg achieved 22.5 per cent body weight in obesity alone (SURMOUNT-1) and clearly outperformed semaglutide head to head on diabetes weight loss (SURPASS-2)
You might also be a good fit if you are flexible on timing
US$ 29.79
US$ 28.94
US$ 22.87
US$ 24.72
